Literature DB >> 31262409

Cutting Edge Acute Ischemic Stroke Management.

Alfredo E Urdaneta1, Paulomi Bhalla2.   

Abstract

Acute ischemic stroke (AIS) is a medical emergency that requires prompt recognition and streamlined work-up to ensure that time-dependent therapies are initiated to achieve the best outcomes. This article discusses frequently missed AIS in the emergency department, the role of various imagining modalities in the work-up of AIS, updates on the use of intravenous thrombolytics and endovascular therapy for AIS, pearls on supportive care management of AIS, and prehospital and hospital process improvements to shorten door-to-needle time.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute ischemic stroke; Endovascular mechanical thrombectomy; Process improvement; Stroke imaging; Stroke management; Stroke window; System improvement

Mesh:

Substances:

Year:  2019        PMID: 31262409     DOI: 10.1016/j.emc.2019.03.001

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  4 in total

Review 1.  Monoclonal antibody as an emerging therapy for acute ischemic stroke.

Authors:  Demi Woods; Qian Jiang; Xiang-Ping Chu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-08-25

2.  Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke.

Authors:  Ping Li; Shuyuan Duan; Adan Fu
Journal:  J Clin Lab Anal       Date:  2019-11-12       Impact factor: 2.352

3.  Long noncoding RNA as a biomarker for the prognosis of ischemic stroke: A protocol for meta-analysis and bioinformatics analysis.

Authors:  Jing Fu; Qian Yu; Jun Xiao; Suping Li
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

4.  Protective effect of microRNA‑340‑5p against oxygen‑glucose deprivation/reperfusion in PC12 cells through targeting neuronal differentiation 4.

Authors:  Juan Wang; Ganzhe Liu
Journal:  Mol Med Rep       Date:  2020-05-22       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.